|
2020
|
Invention
|
Gpr139 receptor modulators. Compounds are provided that modulate the GPR139 receptor, composition... |
|
|
Invention
|
Systems and methods for processing mri data. The present disclosure provides systems and methods ... |
|
|
P/S
|
Downloadable computer software for administering questionnaires, tests, and assessments relating ... |
|
2019
|
Invention
|
1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine de... |
|
|
Invention
|
Systems and methods for screening, diagnosing, and stratifying patients. A system for evaluating ... |
|
|
Invention
|
Multimodal biomarkers predictive of transdiagnostic symptom severity. The method for evaluating m... |
|
|
Invention
|
System and method for identifying transdiagnostic features shared across mental health disorders.... |
|
|
P/S
|
Downloadable computer software for administering behavioral tasks to assess patients' motivation ... |
|
|
Invention
|
Machine learning-based diagnostic classifier. Systems and methods for utilizing machine learning ... |
|
2018
|
Invention
|
Methods and systems for computer-generated predictive application of neuroimaging and gene expres... |
|
|
Invention
|
Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobeha... |
|
|
Invention
|
Vasopressin receptor antagonists and products and methods related thereto. Compounds are provided... |
|
|
Invention
|
2,6-diazaspiro[3.3]hepatan-2-yl derivatives and pharmaceutical compostions thereof useful as vaso... |
|
|
Invention
|
1-(2-azaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine deriva... |
|
|
Invention
|
Quinolinyl compounds and their use as a kappa opioid receptor (kor) antagonists and products and ... |
|
|
Invention
|
Kappa opioid receptor antagonists and products and methods related thereto. Compounds are provide... |
|
2017
|
P/S
|
Pharmaceutical preparations to treat brain disorders. Marketing of pharmaceutical preparations fo... |
